Your browser doesn't support javascript.
loading
Liver Transplantation as Definitive Treatment of Post-cholecystectomy Bile Duct Injury: Experience in a High-volume Repair Center.
Vilatobá, Mario; Chávez-Villa, Mariana; Figueroa-Méndez, Rodrigo; Domínguez-Rosado, Ismael; Cruz-Martínez, Rodrigo; Leal-Villalpando, Rafael P; García-Juárez, Ignacio; Mercado, Miguel A.
Afiliação
  • Vilatobá M; Department of Transplantation.
  • Chávez-Villa M; Department of Transplantation.
  • Figueroa-Méndez R; Department of Internal Medicine.
  • Domínguez-Rosado I; Department of Surgery.
  • Cruz-Martínez R; Department of Transplantation.
  • Leal-Villalpando RP; Department of Anesthesiology.
  • García-Juárez I; Department of Gastroenterology, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubirán, Mexico City, Mexico.
  • Mercado MA; Department of Surgery.
Ann Surg ; 275(5): e729-e732, 2022 05 01.
Article em En | MEDLINE | ID: mdl-35084146
ABSTRACT

OBJECTIVE:

To analyze the perioperative and long-term outcomes of patients undergoing LT due to BDI in a tertiary care center.

BACKGROUND:

BDI is associated with significant morbidity and long-term impact on quality of life. LT represents the only possibility of a cure in patients with BDI who develop SBC.

METHODS:

Retrospective cohort study from a prospective LT database. Between 2008 and 2019, patients with SBC due to BDI after cholecystectomy and requiring LT were identified. Perioperative and long-term outcomes were analyzed.

RESULTS:

Among 354 LT, 12 patients underwent LT to treat post-cholecystectomy BDI and accounted for 3.4% of all LT. The median time from BDI to SBC diagnosis was 9.3 years (2.4-14). The mean time from SBC to inclusion on the waitlist was 2.4years (± 2.2). Postoperative complications occurred in 11 patients (91.6%); mainly infectious (9/12 patients, 75%), followed by renal complications (4/12 patients, 33.3%). Only 2 patients developed major complications, which were the patients who died, resulting in a 90-day mortality of 16.7%. After a mean follow-up of 40.3 months (± 42.2) survival at 1, 3, and 5 years was 83%.

CONCLUSIONS:

Although BDI is an unusual indication for LT worldwide, it accounted for 3.4% of all LT in our center. Although postoperative mortality remains high, LT is the only possibility of a cure, with acceptable long-term outcomes. Early referral to a tertiary care center is essential to avoid long-term complications of BDI, such as SBC.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças dos Ductos Biliares / Transplante de Fígado / Colecistectomia Laparoscópica Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças dos Ductos Biliares / Transplante de Fígado / Colecistectomia Laparoscópica Idioma: En Ano de publicação: 2022 Tipo de documento: Article